KRS 217.826: Basis for reimbursement when substitution forbidden.

Whenever a drug has been prescribed with the indication "Do Not Substitute" for a

patient who has a contract whereunder he is reimbursed for the costs of health care, then

the party that has contracted to reimburse the patient shall make the reimbursement on the

basis of the brand name price and not on the basis of the generic drug price.